EUVIMEDEUVIMED entdecken
Kommentar

Real-world safety of systemic psoriasis therapies: the critical role of registry data

Brigitte Stephan iD

British Journal of Dermatology · 18.08.2026 · 195 (3) · e45-e46

DOI: 10.1093/bjd/ljag250 ↗

Kurz gefasst

Kommentar in der Zeitschrift British Journal of Dermatology, online erschienen am 17.06.2026. Verfasst von Brigitte Stephan. Beteiligte Einrichtung: Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Brigitte Stephan; Antipsoriatic medications and their safety: why seeking for registry data exploration, British Journal of Dermatology, , ljag250, https:/

Autor:innen und Institutionen

  • Institute for Health Services Research in Dermatology and Nursing (IVDP), University Medical Center Hamburg-Eppendorf (UKE), Hamburg, Germany.

ORCID-Profile: Brigitte Stephan

Zitieren

APA

Stephan, B. (2026). Real-world safety of systemic psoriasis therapies: the critical role of registry data. British Journal of Dermatology, 195(3), e45-e46. https://doi.org/10.1093/bjd/ljag250

Vancouver

Stephan B. Real-world safety of systemic psoriasis therapies: the critical role of registry data. British Journal of Dermatology. 2026;195(3):e45-e46. doi:10.1093/bjd/ljag250

BibTeX
@article{Stephan2026,
  author = {Stephan, Brigitte},
  title = {Real-world safety of systemic psoriasis therapies: the critical role of registry data},
  journal = {British Journal of Dermatology},
  year = {2026},
  volume = {195},
  number = {3},
  pages = {e45--e46},
  doi = {10.1093/bjd/ljag250}
}
Kostenlos starten →